These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34070254)

  • 41. The NAMPT inhibitor FK866 reverts the damage in spinal cord injury.
    Esposito E; Impellizzeri D; Mazzon E; Fakhfouri G; Rahimian R; Travelli C; Tron GC; Genazzani AA; Cuzzocrea S
    J Neuroinflammation; 2012 Apr; 9():66. PubMed ID: 22490786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New Analogues of the Nicotinamide Phosphoribosyltransferase Inhibitor FK866 as Potential Anti-Pancreatic Cancer Agents.
    Conforti I; Benzi A; Caffa I; Bruzzone S; Nencioni A; Marra A
    Med Chem; 2024; 20(7):694-708. PubMed ID: 38333979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.
    Cea M; Cagnetta A; Acharya C; Acharya P; Tai YT; Yang C; Lovera D; Soncini D; Miglino M; Fraternali-Orcioni G; Mastracci L; Nencioni A; Montecucco F; Monacelli F; Ballestrero A; Hideshima T; Chauhan D; Gobbi M; Lemoli RM; Munshi N; Treon SP; Anderson KC
    Clin Cancer Res; 2016 Dec; 22(24):6099-6109. PubMed ID: 27287071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.
    Bruzzone S; Fruscione F; Morando S; Ferrando T; Poggi A; Garuti A; D'Urso A; Selmo M; Benvenuto F; Cea M; Zoppoli G; Moran E; Soncini D; Ballestrero A; Sordat B; Patrone F; Mostoslavsky R; Uccelli A; Nencioni A
    PLoS One; 2009 Nov; 4(11):e7897. PubMed ID: 19936064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NAD metabolism fuels human and mouse intestinal inflammation.
    Gerner RR; Klepsch V; Macheiner S; Arnhard K; Adolph TE; Grander C; Wieser V; Pfister A; Moser P; Hermann-Kleiter N; Baier G; Oberacher H; Tilg H; Moschen AR
    Gut; 2018 Oct; 67(10):1813-1823. PubMed ID: 28877980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct effects of Nampt inhibition on mild and severe models of lipopolysaccharide-induced myocardial impairment.
    Liu L; Wang P; Liang C; He D; Yu Y; Liu X
    Int Immunopharmacol; 2013 Oct; 17(2):342-9. PubMed ID: 23831038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fragment-based discovery of a potent NAMPT inhibitor.
    Korepanova A; Longenecker KL; Pratt SD; Panchal SC; Clark RF; Lake M; Gopalakrishnan SM; Raich D; Sun C; Petros AM
    Bioorg Med Chem Lett; 2018 Feb; 28(3):437-440. PubMed ID: 29287958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase.
    Olesen UH; Petersen JG; Garten A; Kiess W; Yoshino J; Imai S; Christensen MK; Fristrup P; Thougaard AV; Björkling F; Jensen PB; Nielsen SJ; Sehested M
    BMC Cancer; 2010 Dec; 10():677. PubMed ID: 21144000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction.
    Montecucco F; Bauer I; Braunersreuther V; Bruzzone S; Akhmedov A; Lüscher TF; Speer T; Poggi A; Mannino E; Pelli G; Galan K; Bertolotto M; Lenglet S; Garuti A; Montessuit C; Lerch R; Pellieux C; Vuilleumier N; Dallegri F; Mage J; Sebastian C; Mostoslavsky R; Gayet-Ageron A; Patrone F; Mach F; Nencioni A
    Antioxid Redox Signal; 2013 Feb; 18(6):630-41. PubMed ID: 22452634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NAMPT pathway is involved in the FOXO3a-mediated regulation of GADD45A expression.
    Thakur BK; Lippka Y; Dittrich T; Chandra P; Skokowa J; Welte K
    Biochem Biophys Res Commun; 2012 Apr; 420(4):714-20. PubMed ID: 22430142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts.
    Xu HN; Feng M; Nath K; Nelson D; Roman J; Zhao H; Lin Z; Glickson J; Li LZ
    Mol Imaging Biol; 2019 Jun; 21(3):426-435. PubMed ID: 30151646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.
    Yang HJ; Yen MC; Lin CC; Lin CM; Chen YL; Weng TY; Huang TT; Wu CL; Lai MD
    Exp Biol Med (Maywood); 2010 Jul; 235(7):869-76. PubMed ID: 20558841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes.
    Pittelli M; Cavone L; Lapucci A; Oteri C; Felici R; Niccolai E; Amedei A; Chiarugi A
    Immunol Cell Biol; 2014 Feb; 92(2):191-9. PubMed ID: 24275857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes.
    Jiang J; Feng M; Jacob A; Li LZ; Xu HN
    Adv Exp Med Biol; 2021; 1269():253-258. PubMed ID: 33966226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting the NAD
    Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
    Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical Redox Imaging Detects the Effects of DEK Oncogene Knockdown on the Redox State of MDA-MB-231 Breast Cancer Cells.
    Wen Y; Xu HN; Privette Vinnedge L; Feng M; Li LZ
    Mol Imaging Biol; 2019 Jun; 21(3):410-416. PubMed ID: 30758703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity.
    Cagnetta A; Cea M; Calimeri T; Acharya C; Fulciniti M; Tai YT; Hideshima T; Chauhan D; Zhong MY; Patrone F; Nencioni A; Gobbi M; Richardson P; Munshi N; Anderson KC
    Blood; 2013 Aug; 122(7):1243-55. PubMed ID: 23823317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
    Hasmann M; Schemainda I
    Cancer Res; 2003 Nov; 63(21):7436-42. PubMed ID: 14612543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer.
    Hong SM; Park CW; Kim SW; Nam YJ; Yu JH; Shin JH; Yun CH; Im SH; Kim KT; Sung YC; Choi KY
    Oncogene; 2016 Jul; 35(27):3544-54. PubMed ID: 26568303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase.
    Zhang LY; Liu LY; Qie LL; Ling KN; Xu LH; Wang F; Fang SH; Lu YB; Hu H; Wei EQ; Zhang WP
    Eur J Pharmacol; 2012 Jan; 674(2-3):163-70. PubMed ID: 22119381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.